3.22.18
SWHR Applauds Congress for Supporting Funding for NIH Office of Research on Women’s Health
SWHR commends Congress for recognizing the valuable role of NIH's Office of Research on Women's Health in the FY18 spending bill by calling for funding that reflects the office's important mission.
2.12.18
SWHR Hires Emily Ortman as Communications Director
SWHR announced today the hiring of Emily Ortman as its new director of communications. Ortman will lead the development of strategic communications efforts to maximize the reach and impact of the Society’s scientific programs and policy activities. She will also oversee implementation of media relations, social media, and website content.
11.29.17 | Sleep
New Guide Aims to Unmask Challenges Women Face in Getting Healthy Sleep
Though sleep is essential to health, the unique barriers faced by women in maintaining good sleep health are often misunderstood or overlooked, according to “Women & Sleep: A Guide for Better Health,” a new resource developed by SWHR.
11.9.17 | Maternal Health
SWHR Receives NICHD Director’s Award for PregSource Partnership
SWHR was awarded the National Institute of Child Health and Human Development's Director’s Award for its participation as a partner agency in PregSourceTM, a crowdsourcing research project that aims to improve knowledge of pregnancy by collecting information directly from pregnant women.
10.27.17 | Alzheimer's Disease
Imaging The Effects Of Menopausal Hormone Therapy On The Brain
Imaging provides a window into brain changes due to dementia decades before someone begins to show clinical symptoms of the disease. Volume of the brain gradually declines with advancing age, but this decline takes a faster course in people who experience more cognitive decline than is expected for their age and go on to develop dementia.
10.27.17 | Alzheimer's Disease
The Importance Of Revamping The Guidelines For Alzheimer’s Disease
An estimated 5.2 million Americans live with Alzheimer’s disease. Of these Americans, 5 million are over the age of 65 years old. AD is the third leading cause of death in older adults, and is the only top 10 cause of death in the U.S. with no disease modifying treatment or proven treatment for prevention.
10.19.17 | Migraine
SWHR Engages on Migraine and Women’s Health
SWHR convened interdisciplinary thought leaders at the George Washington University Milken School of Public Health for a panel discussion that included patients, practitioners, and the employer perspective.
10.19.17
SWHR Elects Roberta L. Gartside as Incoming Board Chair
SWHR announced the unanimous election of Roberta L. Gartside, MD, as the new Chair of its Board of Directors for 2018-2019. As a business leader with a strong commitment to nonprofit service, Dr. Gartside will lead the organization’s mission-based efforts to eliminate imbalances in care for women through science, advocacy, and education.
8.21.17
SWHR Lauds Passage and Signage of FDA Reauthorization Act of 2017 into Law
SWHR congratulates the Congress and the President for approving the Food and Drug Administration (FDA) Reauthorization Act of 2017. By providing significant funding and important improvements to FDA's medical products review and approval process, this law will enable timely access to safe and effective medical innovations to millions of patients who need them.
